it's kind of inevitable that myx will bottom out at some stage soon, the accounts show that the impairments have dropped approximately $500m in net profit over the last three years. Effectively since they overpaid for generics, these losses have also pushed the market cap from a $1.3 billion company to around $5-600 million. Once these impacts are washed out, and the accounts look cleaner (not in the red) with a few other cash generating drugs in the line then a correction to moving upwards in share price to a market cap of around 7-800mill
it's kind of inevitable that myx will bottom out at some...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.15 |
Change
0.130(2.59%) |
Mkt cap ! $418.4M | |||
| Open | High | Low | Value | Volume |
| $5.05 | $5.17 | $5.05 | $571.9K | 111.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | $5.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.17 | 490 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| MYX (ASX) Chart |